SCHEMBL6479936

SCHEMBL6479936

O=S(=O)(Oc1ccccc1)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 15/20 0.45
CA1 P00915 14/20 0.45
CA9 Q16790 3/20 0.45
PIK3CD O00329 1/20 0.45
PIK3CA P42336 1/20 0.45
PIK3CB P42338 1/20 0.45
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.38
PPARG P37231 1/20 0.38
NFE2L2 Q16236 1/20 0.38
JAK2 O60674 1/20 0.38
JAK3 P52333 1/20 0.38
PTK2 Q05397 1/20 0.38
MMP1 P03956 2/20 0.38
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
MMP8 P22894 2/20 0.38
MMP13 P45452 2/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5315919 0.98 PIK3CD (0.44) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL27366575 0.98 PIK3CD (0.44) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL6900759 0.98 CA2 (0.46) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL28289623 0.96 CA2 (0.45) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL575913 0.90 CA2 (0.51) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL7045992 0.90 CA2 (0.51) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL6474468 0.88 CA2 (0.50) CA2CA1CA9PIK3CDPIK3CA
Diphenylsulfane SCHEMBL1772327 0.87 PIK3CD (0.45) CA2CA1CA9PIK3CDPIK3CA
SCHEMBL2572784 0.85 STS (0.45) CA2CA1CA9PIK3CDPIK3CA
Diphenylsulfane SCHEMBL6501320 0.85 STS (0.45) CA2CA1CA9PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118908996-A A composition containing C (sp2) P bond or C (sp)3) Process for preparing organic phosphine compound of-P bond 烟台大学 2024-11-08 CN disclosed
WO-2023242598-A1 BIFUNCTIONAL MOLECULES FOR TARGETED PROTEIN DEGRADATION AMPHISTA THERAPEUTICS LIMITED (GB) 2023-12-21 WO disclosed
US-6919470-B2 Aryl and heteroaryl sulfonates BAYER AKTIENGESELLSCHAFT (DE) 2005-07-19 US disclosed
US-20030232802-A1 Aryl and heteroaryl sulfonates HEIL MARKUS (DE) 2003-12-18 US disclosed
EP-1278722-A1 ARYL AND HETEROARYL SULFONATES Bayer Aktiengesellschaft (DE) 2003-01-29 EP disclosed
WO-2001074763-A1 ARYL AND HETEROARYL SULFONATES BAYER AKTIENGESELLSCHAFT (DE) 2001-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232802-A1 Aryl and heteroaryl sulfonates ARSA, SNCA, ATXN2 CA2 1931/4885CA1 2411/4885CA9 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.